Drug Abuse Testing Market: By Technology (Immunoassay, On-site Testing, Mass Spectrometry and Others), By Sample Type (Urine, Saliva, Blood, Hair and Others) and Geography     

Purchase Option

$ 3000
$ 4400
$ 6660
$ 8900

Drug Abuse Testing (DAT) Market size is valued at USD 2332.84 million in 2021 and is expected to reach USD 2934.80 million by 2028, at a CAGR of 3.9% during the forecast period 2022-2028. testing for drug abuse Urine, hair, oral fluid, breath, and others are all types of market analysis. To keep up with the continual surge in novel chemicals being abused, alternate matrices, and market demands, commercial drug abuse testing techniques have undergone significant modification in recent years. A drug abuse test is a non-invasive technological analysis of biological samples such as blood, hair, urine, and other bodily fluids to detect the presence of illegal or prescription drugs, as well as their metabolites. Urine testing is the most commonly utilised sample type for evaluating drugs of abuse. Drug testing is an important complement to clinical care and substance abuse. Sports organisations, employers, forensic objectives, and a variety of other applications are increasingly using drug testing. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Drug Abuse Testing Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Drug Abuse Testing (DAT) Market DRIVERS AND RESTRAINTS

One of the key drivers for the drug abuse testing industry is the increase in the number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others. Furthermore, technological improvements in drug screening/testing equipment, as well as severe government regulations requiring drug screening, are propelling the market forward. However, in some countries, a lack of awareness and the perception of drug testing as a violation of personal rights limits the growth of the worldwide drug misuse testing market. Emerging markets such as Asia-Pacific and Latin America and the Caribbean (LAMEA) offer significant potential for the drug misuse testing business to expand.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Drug Abuse Testing Market Segmentation

By Technology
  • Immunoassay
  • On-site Testing
  • Mass Spectrometry
  • Others
By Sample Type
  • Urine
  • Saliva
  • Blood
  • Hair
  • Others
By Geography
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Poland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • Gulf Cooperation Council (GCC) Countries
    • South Africa
    • Rest of MEA

Frequently Asked Questions

The Drug Abuse Testing Market is projected to expand at a CAGR of 3.9% during the forecast period.

Abbott Laboratories, Danaher Corporation (Beckman Coulter), LabCorp, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc.

Europe is the fastest-growing region for Drug Abuse Testing Market

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • LabCorp
  • Dragerwerk AG & Co. KGaA
  • Quest Diagnostics Inc.
  • Randox Testing Services
  • United States Drug Testing Laboratories Inc. (USDTL)
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Hoffmann-La Roche Ltd